Discover trends, market shifts, and competitive outlooks for the neuromodulation industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Projected Market Size and Growth Rates for the Neuromodulation Market From 2025 To 2029?

Recently, the neuromodulation market has experienced swift expansion. The market, which is expected to increase from $6.96 billion in 2024 to $7.68 billion in 2025, will do so at a compound annual growth rate (CAGR) of 10.3%. The notable growth during the past years is linked to the increasing instances of chronic diseases, relevant clinical findings and research, patient preference for non-invasive treatments, government policies and funding, expansion of treatment indications, and collaborations and partnerships.

Over the coming years, the neuromodulation market is anticipated to experience fast-paced expansion, with expectations to reach an impressive size of “$11.79 billion in 2029, reflecting a compound annual growth rate (CAGR) of 11.3%. The anticipated growth in this period can be explained by several factors, including the shrinking of devices, increased attention on neurological disorders among the elderly, broader usage in the psychiatric field, patient-oriented methods, and improved global healthcare accessibility. Trends that are expected to stand out include the incorporation of artificial intelligence (AI), technological advancements, non-invasive techniques of neuromodulation, closed-loop neuromodulation systems, expansion of specifications, as well as the introduction of wireless and wearable neuromodulation devices.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10142&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theNeuromodulation Market?

The rise in occurrences of neurological disorders is anticipated to fuel the expansion of the neuromodulation market in the future. Neurological issues, technically considered ailments that impact the brain, the nerves dispersed across the human body, and the spinal cord, can be treated and modulated by neuromodulation. This includes a spectrum of neurological diseases and disorders like Parkinson’s and Alzheimer’s. For example, the European Brain Council, a Belgium-based international health coordination organization, reported in April 2022 that there were more than 600 neurological diseases and close to 300 psychiatric conditions recognized. Globally, there were 50 million people coping with Alzheimer’s and other forms of dementia. Epilepsy, another ubiquitous disorder, affected 65 million individuals worldwide. In Europe alone, there were 10.5 million people diagnosed with dementia, a figure that’s expected to surge to 18.7 million by 2050. Consequently, the increasing incidence of neurological disorders is stimulating the neuromodulation market’s growth.

Which Segments in the Neuromodulation Offer the Most Growth?

The neuromodulation market covered in this report is segmented –

1) By Technology: Internal Neuromodulation, External Neuromodulation (Non-invasive)

2) By Biomaterial: Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial

3) By Application: Chronic Pain, Urinary And Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, Other Applications

4) By End-User: Hospitals, Clinics, Home Healthcare

Subsegments:

1) By Internal Neuromodulation: Implantable Devices, Intrathecal Drug Delivery Systems

2) By External Neuromodulation (Non-invasive): Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), Transcutaneous Electrical Nerve Stimulation (TENS), Peripheral Nerve Stimulation (PNS)

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=10142&type=smp

What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theNeuromodulation Market?# Market?

North America was the largest region in the neuromodulation market in 2024. The regions covered in the neuromodulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Current Market Growth and Trends in the Neuromodulation Industry?

There is an increasing trend for technological developments within the neuromodulation market. Major businesses within this industry are focusing heavily on creating new tech-solutions to solidify their market standing. For instance, GrayMatters Health, a company from Israel with expertise in digital self-neuromodulation therapies, introduced its innovative product, Prism, to the market in January 2024. This FDA-approved therapy for PTSD utilizes an EEG cap and software that assists patients in controlling emotional responses through neurofeedback. This cutting-edge technology complements traditional psychotherapy and pharmacotherapy, giving patients an active role in symptom management. In December 2022, Abbott Laboratories, a U.S. based firm in the medical devices and healthcare field, unveiled the Eterna spinal cord stimulation (SCS) system – the smallest implantable, rechargeable spinal cord stimulator currently available. The Eterna SCS utilizes Abbott’s exclusive low-dose BurstDR stimulation, the only SCS waveform advancement with the top-level 1A evidence of effectiveness, proven to reduce pain by 23% more than standard waveform tech-approaches.

View the full report here:

https://www.thebusinessresearchcompany.com/report/neuromodulation-global-market-report

What Are the Key Elements That Define the Neuromodulation Market?

Neuromodulation is the modification of nerve activity (or modulation) by delivering electrical or pharmacological substances directly to a specific location. It is a reversible procedure performed to relieve pain.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10142

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model